Synthroid and Norgesic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Synthroid (levothyroxine sodium) and Norgesic (aspirin; caffeine; orphenadrine citrate). Common drug interactions include thrombosis among females.

The phase IV clinical study analyzes what interactions people have when they take Synthroid and Norgesic. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Synthroid?

Synthroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 249,205 Synthroid users. Check the latest studies of Synthroid.

What is Norgesic?

Norgesic has active ingredients of aspirin; caffeine; orphenadrine citrate. eHealthMe is studying from 330 Norgesic users. Check the latest studies of Norgesic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

14 people who take Synthroid and Norgesic together, and have interactions are studied.

Synthroid and Norgesic drug interactions.

What are the common drug interactions of Synthroid and Norgesic, by gender? *:

female:

  1. Thrombosis (formation of a blood clot inside a blood vessel)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Nausea (feeling of having an urge to vomit)
  4. Pain in extremity
  5. Staphylococcal abscess (pus formation due to staphylococcal bacteria)
  6. Visual field defect
  7. Abscess limb (limb infection)
  8. Anaemia (lack of blood)
  9. Application site reaction
  10. Bladder dilatation

male:

n/a

What are the common drug interactions of Synthroid and Norgesic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Application site reaction
  2. Burning sensation
  3. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  4. Diplopia (double vision)
  5. Drug effect decreased
  6. Exercise tolerance decreased
  7. Eye infection
  8. Fatigue (feeling of tiredness)
  9. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  10. General symptom

50-59:

  1. Bladder dilatation
  2. Blood cholesterol increased
  3. Blood triglycerides increased
  4. Cellulitis (infection under the skin)
  5. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  6. Culture urine positive
  7. Diarrhoea
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Emotional distress
  10. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

60+:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Oxygen saturation decreased
  4. Swollen tongue (swelling of tongue)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 35.71%
  2. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 14.29%
  3. Muscle Spasms (muscle contraction): 2 people, 14.29%
  4. Migraine (headache): 2 people, 14.29%
  5. Headache (pain in head): 2 people, 14.29%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
  7. Urinary Tract Infection: 1 person, 7.14%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
  9. Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
  10. Constipation: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Synthroid and Norgesic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Synthroid and Norgesic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Synthroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Norgesic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Synthroid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norgesic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and aspirin; caffeine; orphenadrine citrate (the active ingredients of Synthroid and Norgesic, respectively), and Synthroid and Norgesic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: